Oxbryta Lawsuit
Treatment Risks and the 2024 Global Recall Pfizer’s Oxbryta (Voxelotor) was marketed as a breakthrough for Sickle Cell Disease, but a 2024 global withdrawal has sparked a wave of legal claims. New clinical data reveals a “devastating paradox”: the drug may actually increase the frequency of life-threatening Vaso-Occlusive Crises (VOCs) and death. If you or a loved one suffered a stroke, organ failure, or severe pain crises while taking Oxbryta, you may be eligible for compensation. Learn about the current 2026 litigation updates and your legal rights in this growing pharmaceutical liability case.
